Erlocip 100 mg Tablet
  1. Home
  2. Pharma Products
  3. Cipla Ltd
  4. Erlocip 100 mg Tablet

Erlocip 100 mg Tablet

Erlocip 100 mg Tablet contains erlotinib 100 mg, a targeted anticancer medicine used mainly for non-small cell lung cancer and pancreatic cancer. It is an oral tablet taken according to the treatment plan prescribed by the oncologist. Erlotinib works by blocking EGFR signaling, which helps slow the growth and spread of cancer cells.

BUY NOW

Category

Erlocip 100 mg Tablet is indicated for certain patients with advanced or metastatic non-small cell lung cancer and pancreatic cancer. Erlotinib belongs to the tyrosine kinase inhibitor class and acts on the epidermal growth factor receptor pathway involved in cancer-cell growth. The dosage and treatment duration are determined by the treating oncologist according to the cancer type and patient’s response to treatment. Regular medical follow-up may be required to monitor treatment response and possible adverse effects.

Technical Specification

Specification Details
Active Ingredient Erlotinib
Strength 100 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 30 Tablets
Manufacturer Cipla Ltd.

Product Also Known As

Erlocip 100 mg Tablet, Erlocip 100 Tablet, Erlocip Erlotinib Tablet, Erlotinib 100 mg Tablet, Erlotinib Lung Cancer Tablet, Erlotinib EGFR Inhibitor Tablet